SOURCE: Healtheuniverse Inc.

March 06, 2006 11:00 ET

Healtheuniverse Files Patent With the U.S. Patent and Trademark Office Covering Non-Embryonic Stem Cell Generation Using Fat Cells

COVINA, CA -- (MARKET WIRE) -- March 6, 2006 -- Healtheuniverse Inc. (OTC: HLUN), a diversified biotechnology development firm specializing in the development and commercialization of patented biopharmaceutical and biomedical products, announced today that it has filed a patent application with the U.S. Patent and Trademark Office, for the method for producing specific tissue cells and hormone secreting cells from non-embryonic stem cells. This invention to produce stem cells from fat via the Company's propriety process is now protected. This technology has applications in every area of the regenerative medicine market which is estimated to grow to $500 billion by 2010.

Healtheuniverse is using this proprietary and patented stem cell technology initially for commercial purposes within the plastic, reconstructive, and cosmetic surgery market to generate a substantial amount of revenue and earnings. During this phase the Company will further pursue the application of our stem cell projects towards finding cures of various diseases that plague our world today; including AIDS, hepatitis, avian flu, leukemia and various forms of cancer.

Dr. Vipul Dev, MD Chief Executive Officer of Healtheuniverse, Inc., stated, "The value that intellectual property brings to a company is largely overlooked and mostly underestimated by the general public and even investors. Two-thirds of the estimated $7 trillion market value of all publicly traded U.S. companies lies with their patents and intellectual property assets. We have several initiatives under way and will legally protect our interests as we move to clinical trials for commercial applications in the field of regenerative medicine utilizing adult stem cells."


HEALTHeUNIVERSE Inc. is a biotechnology development firm specializing in the development and commercialization of patented Biopharmaceutical and Biomedical products. We are engaged in research and development of regenerative medicine therapies using non-embryonic adult stem cells for use in plastic, reconstructive, orthopedic, vascular, and cardiac surgery. Healtheuniverse strives to be the first to commercialize the use of regenerative medicine in plastic and reconstructive surgery and to develop therapeutic uses in the most profitable commercial applications. More information on Healtheuniverse is available online at

Safe Harbor Statement

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Healtheuniverse Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Contact Information

  • For more information, please contact:
    Healtheuniverse Inc.
    Investor Relations
    Email Contact